Biomarkers for the Prediction of Heart Failure and Cardiovascular Events in Patients with Type 2 Diabetes: A Position Statement from the Heart Failure Association of the European Society of Cardiology
Year: 2022
Type: article
Abstract: Knowledge on risk predictors of incident heart failure (HF) in patients with type 2 diabetes (T2D) is crucial given the frequent coexistence of the two conditions and the fact that T2D doubles the risk of incident HF. In addition, HF is increasingly being recognized as an important endpoint in trials in T2D. On the other hand, the diagnostic and prognostic performance of established cardiovascular biomarkers may be modified by the presence of T2D. The present position paper, derived by an expert panel workshop organized by the Heart Failure Association of the European Society of Cardiology, summarizes the current knowledge and gaps in evidence regarding the use of a series of different biomarkers, reflecting various pathogenic pathways, for the prediction of incident HF and cardiovascular events in patients with T2D and in those with established HF and T2D.
DOI: 10.1002/ejhf.2575
Authors: Peter Seferović, Dimitrios Farmakis, Antoni Bayes-Genis, Tuvia Ben Gal, Michael Böhm, Ovidiu Chioncel, Roberto Ferrari, Gerasimos Filippatos, Loreena Hill, Ewa Jankowska, Mitja Lainscak, Yuri Lopatin, Lars H. Lund, Alexandre Mebazaa, Marco Metra, Brenda Moura, Giuseppe Rosano, Thomas Thum, Adriaan Voors, Andrew J.S. Coats
Institutions: Serbian Academy of Sciences and Arts, University of Belgrade, University of Cyprus, Universitat Autònoma de Barcelona, Centro de Investigación en Red en Enfermedades Cardiovasculares, Hospital Universitari Germans Trias i Pujol, Tel Aviv University, Rabin Medical Center, Universitätsklinikum des Saarlandes, Saarland University, Carol Davila University of Medicine and Pharmacy, University of Ferrara, Maria Cecilia Hospital, National and Kapodistrian University of Athens, University General Hospital Attikon, Queen's University Belfast, Wroclaw Medical University, University of Ljubljana, Volgograd State Medical University, Karolinska University Hospital, Karolinska Institutet, Inserm, Marqueurs cardiovasculaires en situation de stress, University of Brescia, Centre for Health Technology and Services Research, University of London, St George's Hospital, St George's, University of London, IRCCS San Raffaele Roma, Medizinische Hochschule Hannover, Fraunhofer Institute for Toxicology and Experimental Medicine, Research Center for Translational Regenerative Medicine, University Medical Center Groningen, University of Groningen, University of Warwick
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4282943159